However, increasing SRD5A2 expression in BPH-1 cells through miR-1199-5p inhibitor transfection did not lead to the development of finasteride (100 μM) sensitivity in BPH-1 cells (Fig. 3 F). This evidence concerns the gene SRD5A2 and benign prostatic hyperplasia.